GAM Holding’s Urovant Sciences Ltd. UROV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-25,600
Closed -$413K 350
2020
Q4
$413K Buy
+25,600
New +$317K 0.02% 213

GAM Holding's UROV Position: Q1 2021 in Review

GAM Holding sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 25,600 shares — an estimated $413K sold.

GAM Holding first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $413K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • GAM Holding reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • GAM Holding sold 25,600 Urovant Sciences Ltd. shares in Q1 2021, an estimated $413K.
  • GAM Holding first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • GAM Holding's Urovant Sciences Ltd. position peaked at $413K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on GAM Holding's 13F filing for Q1 2021, filed 10 May 2021.